Antidepressants: Pregnancy
The question
To ask the Secretary of State for Health and Social Care, whether his Department has undertaken research into the potential impact of anti-depressants during pregnancy on unborn babies.
Answered by Dr Zubir Ahmed
The Department through its research delivery arm, the National Institute for Health and Care Research (NIHR), has funded research into this topic. Examples of relevant research include a study exploring antidepressant use during pregnancy to assess the benefits to mothers and long-term neurodevelopmental risks to children, and a project which aimed to create a computerised decision support tool to guide discussions between doctors and pregnant women about medication risks and benefits, ensuring a balance between maternal health and foetal protection.
In addition, the NIHR has supported research which investigated Neonatal Adaptation Syndrome, a cluster of symptoms like jitteriness and feeding difficulties, in babies exposed to selective serotonin reuptake inhibitors or selective noradrenaline reuptake inhibitors antidepressants in utero. This research aimed to understand the experiences of mothers and monitoring practices.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →